Login / Signup

Efficacy of proteasome inhibitor-based maintenance following autologous transplantation in multiple myeloma: A systematic review and meta-analysis.

Ricardo D ParrondoTea ReljicMadiha IqbalErnesto AyalaMohamed A Kharfan-DabajaAmbuj KumarHemant S Murthy
Published in: European journal of haematology (2020)
PIM following AHCT in MM improves PFS and DOHR without an increase in development of SPM or severe PN compared with placebo/thalidomide.
Keyphrases
  • multiple myeloma
  • cell therapy
  • bone marrow
  • early onset
  • double blind
  • platelet rich plasma
  • clinical trial
  • phase iii
  • drug induced
  • mesenchymal stem cells
  • placebo controlled